Your browser doesn't support javascript.
loading
Correction: the TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.
Vera, R; Castro, N; Labiano, I; Lecumberri, A; Huerta, A E; Arasanz, H; Caseda, I; Ruiz-Pace, F; Viaplana, C; Arrazubi, V; Hernandez-Garcia, I; Mata, E; Gomez, D; Laguna, S; Suarez, J; Fernandez-De-Los-Reyes, I; Rullan, M; Estremera, F; Alonso, V; Pazo-Cid, R; Gil-Negrete, A; Lafuente, A; Martin-Carnicero, A; Dienstmann, R; Alsina, M.
Afiliação
  • Vera R; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Castro N; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Labiano I; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Lecumberri A; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Huerta AE; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Arasanz H; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Caseda I; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Ruiz-Pace F; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Viaplana C; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Arrazubi V; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Hernandez-Garcia I; Oncology Data Science Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Mata E; Oncology Data Science Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Gomez D; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Laguna S; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Suarez J; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Fernandez-De-Los-Reyes I; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Rullan M; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Estremera F; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Alonso V; Oncobiona Group, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Pazo-Cid R; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Gil-Negrete A; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Lafuente A; Department of Surgery, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Martin-Carnicero A; Department of Pathology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
  • Dienstmann R; Molecular Pathology of Cancer Group, Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Alsina M; Department of Gastroenterology and Hepatology, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
BMC Cancer ; 24(1): 819, 2024 Jul 09.
Article em En | MEDLINE | ID: mdl-38982387
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BMC Cancer Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BMC Cancer Ano de publicação: 2024 Tipo de documento: Article